ImageneBio, Inc. — Director's Dealing 2026

Jan 3, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ImageneBio, Inc. (IMA)
CIK: 0001835579
Period of Report: 2025-12-30

Reporting Person: Butler Erin (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-12-30	Common Stock	A	22500	—	Acquired	25551	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-12-30	Employee Stock Option (right to buy)	$7.11	A	22500	Acquired	2035-12-30	Common Stock (22500)	Direct

Footnotes

F1: Represents the number of shares of the Issuer's common stock ("Common Stock") underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of Common Stock upon settlement. 25% of RSUs will vest and settle into Common Stock on July 15, 2026, March 1, 2027, March 1, 2028 and March 1, 2029, in each case, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2025 Equity Incentive Plan (the "2025 Plan")) through each such date.

F2: This option vests over four years, with 25% of the shares subject to this option vesting on July 15, 2026, and the remaining shares vesting in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the 2025 Plan) through each such date.